AbbVie
ABBV
3,925 hedge funds and large institutions have $294B invested in AbbVie in 2025 Q3 according to their latest regulatory filings, with 296 funds opening new positions, 1,666 increasing their positions, 1,475 reducing their positions, and 102 closing their positions.
190% more first-time investments, than exits
New positions opened: 296 | Existing positions closed: 102
45% more funds holding in top 10
Funds holding in top 10: 150 → 218 (+68)
16% more call options, than puts
Call options by funds: $4.29B | Put options by funds: $3.71B
13% more repeat investments, than reductions
Existing positions increased: 1,666 | Existing positions reduced: 1,475
3% more funds holding
Funds holding: 3,794 → 3,925 (+131)
0.98% less ownership
Funds ownership: 72.98% → 71.99% (-0.98%)
23% less capital inflows, than outflows
Capital inflows: $9.09B | Capital outflows: $11.8B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.76B |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$361M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$358M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$314M |
| 5 |
Amundi
Paris,
France
|
+$288M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$600M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$412M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$373M |
| 4 |
BlackRock
New York
|
-$301M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$251M |
ABBV Hedge Fund Activity: Q3 2025 in Review
3,925 of the 7,655 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2025, worth a combined $294B — up 23% from $239B a quarter earlier.
Buyers outnumbered sellers: 296 funds opened new ABBV positions and 102 closed out — a net gain of 194 holders — while 1,666 added to existing stakes and 1,475 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $1.76B. The largest seller was Capital International Investors, cutting an estimated $600M.
- 3,925 institutional investors held AbbVie (ABBV) as of Q3 2025, up from 3,794 in Q2 2025.
- Funds reported $294B of AbbVie stock for Q3 2025, up 23% quarter-over-quarter.
- 296 funds opened new AbbVie positions in Q3 2025 and 102 closed out, a net change of +194 holders.
- The largest AbbVie buyer in Q3 2025 was Wellington Management Group, an estimated $1.76B added.
- The largest AbbVie seller in Q3 2025 was Capital International Investors, an estimated $600M sold.
Based on aggregated 13F filings for Q3 2025.